Nudges and Incentives to Enhance the Opioid Treatment Workforce

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions
Opioid Abuse (Disorder)
Interventions
BEHAVIORAL

Phase 1 Condition 1

Providers assigned to this condition will be sent recruitment materials that are 'recruitment as usual' (Phase 1 Condition 1). These materials will not include prosocial messaging and will not include an additional mention of financial support available for participation.

BEHAVIORAL

Phase 1 Condition 2

Providers assigned to this condition will be sent recruitment materials that include an additional mention of financial support available for participation, but will not include prosocial messaging (Phase 1 Condition 2).

BEHAVIORAL

Phase 1 Condition 3

Providers assigned to this condition will be sent recruitment materials that include prosocial messaging, but do not include an additional mention of financial support available for participation (Phase 1 Condition 3).

BEHAVIORAL

Phase 1 Condition 4

Providers assigned to this condition will be sent recruitment materials that include prosocial messaging and an additional mention of financial support available for participation (Phase 1 Condition 4).

BEHAVIORAL

Phase 2 Condition 1

Providers who enroll in the study and are assigned to this condition will be in this group. Other than the opportunity to participate in a learning collaborative, participants receive no compensation.

BEHAVIORAL

Phase 2 Condition 2

Providers who enroll in the study and are assigned to this condition will be in this group. In addition to the opportunity to participate in the learning collaborative, participants receive a reimbursement at 30% of the NC Medicaid rate for a patient visit.

BEHAVIORAL

Phase 2 Condition 3

Providers who enroll in the study and are assigned to this condition will be in this group. In addition to the opportunity to participate in the learning collaborative, participants receive a reimbursement at 100 percent of the NC Medicaid rate for a patient visit for their time participating in the learning collaborative.

Trial Locations (1)

27599-7411

University of North Carolina At Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03834025 - Nudges and Incentives to Enhance the Opioid Treatment Workforce | Biotech Hunter | Biotech Hunter